Drug Topics
APRIL 18, 2025
The approval is based on 2 phase 3 studies demonstrating reductions in itch severity and urticaria activity as a composite of itch and hives at 24 weeks.
PharmaVoice
APRIL 18, 2025
Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 18, 2025
Luke Turnock, PhD, MSc, discussed current trends in the promotion of lifestyle enhancement drugs for populations they are not approved for.
STAT
APRIL 18, 2025
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, and hold yet another listening party, where the rotation will likely include this , this , this , this and this.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 18, 2025
John Riggi, national advisor for cybersecurity and risk at the American Hospital Association, discusses how pharmacists can assess their stores vulnerability to cyberattacks.
STAT
APRIL 18, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, and happy Friday! Today’s the last day you’ll hear from me for a couple weeks. I’m taking off on a big trip with some of my best friends. But don’t worry, you’ll be in good hands with a cast of STAT reporters while I’m away.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
APRIL 18, 2025
Levetiracetam , known by the brand name Keppra, is an important medication for many people who live with seizure disorders. If youve been prescribed levetiracetam, its usually on a long-term basis so you might wonder about drinking alcohol while attending social events or simply unwinding after work. Unfortunately, mixing alcohol with levetiracetam is generally not recommended as it can increase side effects like drowsiness and dizziness or increase the risk of seizures.
Drug Topics
APRIL 18, 2025
The recommendation includes patients 12 years and older traveling to a country where there is a chikungunya outbreak or where there is an elevated risk for US travelers.
The Checkup by Singlecare
APRIL 18, 2025
Research shows that men are generally more susceptible to seizures than women, and gabapentin (sold under the brand names Neurontin and Gralise ) is one of the most common anticonvulsant medications out there. In fact, its kind of a jack-of-all-trades drug, approved by the Food and Drug Administration (FDA) to treat epilepsy, postherpetic neuralgia, and restless leg syndrome.
Drug Topics
APRIL 18, 2025
Crystal Hodge discusses R naughts and the measures of how contagious measles is.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
APRIL 18, 2025
Multiple phase 3 clinical trials demonstrated dupilumabs (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.
DiversifyRx
APRIL 18, 2025
To be great, it is best to learn from greats. Doesn’t matter if they are a pharmacy owner or a gold medalist. Greatness often has a pattern, and here are some lessons pharmacy owners can learn from some sports legends. Let’s get you thinking with a sports pharmacy mindset! Let me ask you a question: When was the last time you did something for the first time?
European Pharmaceutical Review
APRIL 18, 2025
Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist , taken without food and water restrictions, to successfully complete a Phase III trial. “ ACHIEVE-1 is the first of seven Phase III studies examining the safety and efficacy of orforglipron across people with diabetes and obesity.
Pharmacy Times
APRIL 18, 2025
Cases have been confirmed in Mexico and Canada.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
APRIL 18, 2025
Plenvu (polyethylene glycol with electrolytes) is a prescription bowel preparation solution used to clean the colon before a colonoscopy. A clean colon improves visibility during the procedure and helps detect abnormalities like ulcers and polyps. How much does Plenvu cost without insurance? The average cash price of Plenvu is typically about $204 per two-dose box.
Pharmacy Times
APRIL 18, 2025
Lepodisiran, a small interfering RNA, demonstrated cholesterol-lowering effects at 16-mg, 96-mg, and 400-mg doses, with the highest dose being the most effective.
Pharma Marketing Network
APRIL 18, 2025
The pace of transformation in healthcare marketing has accelerated dramatically in recent years. As we dive deeper into 2025, the convergence of digital technology, patient-centric strategies, and precision targeting is redefining how pharma brands communicate with both healthcare professionals and patients. No longer is it enough to rely on traditional outreach methods or static content campaigns.
Pharmacy Times
APRIL 18, 2025
The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared to other weight loss and diabetes medications.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
APRIL 18, 2025
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharma Marketing Network
APRIL 18, 2025
In an age of disruption, where marketing playbooks are rewritten overnight, staying current on pharma marketing news is no longer a luxuryit’s a necessity. For pharma brands navigating the 2025 landscape, real-time insight into market trends, regulatory shifts, and competitive moves can mean the difference between stagnation and strategic advantage.
pharmaphorum
APRIL 18, 2025
New FDA head says no more pharma on advisory committees Jonah.
STAT
APRIL 18, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today we talk about Eli Lilly’s stock jumping after it released new data on its GLP-1 pill, see Sanofi partner with a mysterious company, and more.
Fierce Healthcare
APRIL 18, 2025
The Department of Government Efficiency is continuing its march to control all healthcare grant dollars leaving the federal government.
pharmaphorum
APRIL 18, 2025
WHO (sans US) finishes draft pandemic preparedness agreement Jonah.
Pharmaceutical Commerce
APRIL 18, 2025
By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI pilotitis and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.
Pharmacy Times
APRIL 18, 2025
The 2025 SPPCP Virtual Conference on Tuesday, May 20, 2025, will offer pharmacists and clinicians a full day of CE-accredited sessions on complex pain management, opioid use disorder, mentorship, and innovative approaches in palliative care, with opportunities for networking and professional development.
Fierce Healthcare
APRIL 18, 2025
Elevance Health projected it will beat its earnings guidance in the first quarter and said medical costs are in line with expectations, contrasting with UnitedHealth Group's disappointing Q1 results.
Pharmacy Times
APRIL 18, 2025
This shift brings new responsibilities and opportunities, from managing inventory changes to counseling patients on alternative therapies.
Fierce Healthcare
APRIL 18, 2025
Financial cost remains one of the biggest barriers to fertility care. At the same time, people going through the fertility journey must deal with the emotional toll it can take.
Pharmacy Times
APRIL 18, 2025
Authors of a review published in The Journal of Allergy and Clinical Immunology emphasized that blood eosinophil count and fractional exhaled nitric oxide cannot be relied on.
pharmaphorum
APRIL 18, 2025
GSK cements Blenrep comeback with MHRA approval Jonah.
Pharmacy Times
APRIL 18, 2025
Sequencing of antibody-drug conjugates (ADCs) in HER2-mutated breast cancer is crucial for optimizing treatment outcomes.
PharmExec
APRIL 18, 2025
Dupixent is the first new targeted therapy to receive FDA-approval for chronic spontaneous urticaria in adults and adolescents over 12 years of age in over a decade.
Expert insights. Personalized for you.
316 
Let's personalize your content